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Abstract
Background: Microglia/macrophages are known to play important roles in initiating brain inflammation after
spontaneous intracerebral hemorrhage (ICH). T cell immunoglobulin and mucin domain-3 (Tim-3) have been proven
to play a critical part in several inflammatory diseases through regulation of both adaptive and innate immune
responses. Tim-3 can be expressed by microglia/macrophages and regulates their function in the innate immune
response. However, the effect of Tim-3 on inflammatory responses following ICH is unclear.
Methods: In this study, we investigated Tim-3 expression, the inflammatory cytokines tumor necrosis factor-α
(TNF-α) and interleukin-1β (IL-1β), and brain water content in peri-hematomal brain tissue at 12 hours and at 1, 3, 5,
and 7 days post-ICH in wild type (WT) ICH and Tim-3−/− ICH mice. The numbers of Tim-3 positive cells,astrocytes,
neutrophils and microglia/macrophages were detected using immunofluorescence staining. Cytokines were
measured by ELISA. Double immunoflurorescence labeling was performed to identify the cellular source of Tim-3
expression. Mouse neurological deficit scores were assessed through animal behavior.
Results: Expression of Tim-3 increased early in mouse peri-hematomal brain tissue after autologous blood injection,
peaked at day 1, and was positively correlated with the concentrations of TNF-α, IL-1β, and brain water content.
Tim-3 was predominantly expressed in microglia/macrophages. Compared with WT mice, Tim-3−/− mice had
reduced ICH-induced brain inflammation with decreased TNF-α and IL-1β, cerebral edema and neurological
deficit scores. Moreover, Tim-/- inhibited activation of microglia/macrophages. The number of activated microglia/
macrophages in Tim-3−/− ICH mice was much lower than that in WT ICH mice.
Conclusions: Our findings demonstrate that Tim-3 plays an important role in brain inflammation after ICH, and
may be a potential treatment target.
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Background
Spontaneous intracerebral hemorrhage (ICH) is a com-
mon disease with high mortality and morbidity, account-
ing for 15 to 20% of all stokes and affecting more than 2
million people worldwide each year [1,2]. The mortality
rate of ICH is more than 40% and only 20% of survivors
can live independently within six months [3]. But until
now, there has been no satisfactory treatment in clinical
practice, mainly because the mechanisms of brain dam-
age after ICH are unclear. Increasing researches show
that inflammatory response plays an important role in
ICH-induced secondary brain damage [4,5]. Brain in-
flammation after ICH is characterized by accumulation
of activated inflammatory cells, such as blood-derived
cells (macrophages, leukocytes) and brain resident cells
(astrocytes, microglia and mast cells). These reactive
cells can release inflammatory mediators, including che-
mokines, cytokine, protease, prostaglandins and other
immunoactive molecules [6,7]. The microglia are the first
cells to react to brain damage among all the inflammatory
cells. Activated microglia have a similar shape to the
blood-derived macrophages, therefore microglia are also
called as the brain macrophages. Increasing evidence
indicates that microglia/macrophages are activated early
following ICH, and release a series of toxic factors, includ-
ing chemokines, cytokines, reactive oxygen species (ROS),
cyclooxygenase-2, protease, heme oxygenase-1 and prosta-
glandins [8-10]. Therefore, microglia/macrophages play
important roles in the secondary brain damage. Tim-3 is a
new immuno-regulation molecule found in 2002, which is
expressed specially in activated Th1 cells [11,12]. More-
over, it has been proven that Tim-3 is also expressed in
the cells of the innate immune system, including macro-
phages, mast cells and dendritic cells [13,14]. Tim-3
expression in microglia/macrophages can be upregulated
and induce the production of proinflammatory cytokines,
such as tumor necrosis factor-a (TNF-a) and interleukin-
1β (IL-1β), which can aggravate inflammation and second-
ary brain damage [14]. However, until now, the effect of
Tim-3 on inflammatory response following ICH has been
unclear. Considering that the microglia/macrophages are
the key cells for inducing brain inflammation and second-
ary brain damage, and that Tim-3 can regulate the
function of microglia/macrophages, we hypothesized that
Tim-3 possibly took part in ICH-induced inflammation by
regulating the function of microglia/macrophages. This
experiment was done to prove our hypothesis.
Materials and methods
Intracerebral hemorrhage model
The ICH model of mice was established using the
method described previously [15]. Animals were anes-
thetized with chloral hydrate (40 mg/kg, intraperitoneal
injection). A catheter plugged in the right femoral artery
was used to monitor continuous blood pressure and to
take blood sampling. Mice were fixed in a stereotactic
frame (Stoelting, Kiel, WI, USA). The puncture point
was located 1 mm anterior to the bregma and 2.5 mm
lateral to midline. A 1-mm cranial hole was drilled with
dental bit and a 27-gauge needle was inserted stereotax-
ically into the right basal ganglia (4 mm deep). Then,
25 μL of autologous blood was injected using a micro-
infusion pump at a rate of 2.5 μL/min. After the infusion,
the needle was kept in the place for another 10 minutes to
prevent blood leakage, and then the needle was pulled
out. The cranial hole was sealed with bone wax and the
skin was sutured. Control mice were injected with 25 μL
0.9% saline. Then mice were allowed to recover. During
operation, rectal temperature of mice was maintained
at 37 ± 1°C. Mean arterial blood pressure (MABP)
(mmHg), arterial pH, arterial PO2, PCO2, Hb (g/L),
and glucose levels (mg/dL) were monitored and main-
tained for stability.
Animals and grouping
C57BL/6 mice (male, 8 to 10 weeks old, and weight 20
to 25 g) were purchased from the Animal House Center,
Medical College of Shangdong University (Jinan, China).
Transgenic line Tim-3−/− mice (8 to 10 weeks old, weight
20 to 24 g) were purchased from American Jackson
Laboratories (Bar Harbor, ME, USA) and were back-
crossed to C57BL/6 mice more than eight times. All
animals were housed in individual cages under a 12 hr/
12 hr light–dark cycle with temperature 21 ± 1°C, humidity
50 to 60% and free access to food and water. All animals
care and experimental protocols were approved by theani-
mal Ethics Committee of the Sandong University. All
efforts were made to minimize the animals’ pain and to
reduce the number of animals. Different experimental
groups were included: 1) For the WT sham group (n = 60),
25 μL of 0.9% saline was injected into the brain of these
mice. 2) For the WT ICH group (n = 60), 25 μL of autolo-
gous blood was injected into the right basal ganglia. 3) For
the Tim-3−/− sham group (n = 50),the operation was the
same as for the WT sham group. 4) For the Tim-3−/− ICH
group (n = 50),the operation was the same as for the WT
ICH group. A total of 8 mice (5 mice in the WT ICH
group and 3 mice in the Tim-3−/− ICH group) died in our
experiment, and the number of mice supplemented was
the same. There were 228 mice in our experiment.
Tissue preparation
In the WT sham group and the WT ICH group, 12 mice
were anesthetized at each of the following time points:
12 hours and 1, 3, 5, and 7 days after injection. Half of
the mice (n = 6) were directly decapitated and their
brains were obtained to store at −80°C for use inreal-
time RT-PCR, in ELISA and to determine brain water
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content. The others (n = 6) were used for immunofluor-
escence. These mice underwent transcardial perfusion
with 200 ml of phosphate buffered saline (PBS), followed
by 100 ml of 4% paraformaldehyde (PFA) in 0.1 M PBS
as described before [16]. The brains were removed and
postfixed for 24 hours in 4% PFA, and then were placed
in 30% sucrose until sinking. Coronal brain sections of
10 μm thickness were obtained with a freezing microtome
(Leica, Nussloch, Germany) and were kept at −20°C. In
the Tim-3−/− sham group and Tim-3−/− ICH group, 10
mice were killed at each of the following time points:
12 hours and 1, 3, 5, and 7 days after operation, Among
this total, 6 mice were used for real-time RT-PCR, for
ELISA and to determine brain water content, and the
others (n = 4) were used for immunofluorescence.
Immunofluorescence staining and cell counting
After being washed in PBS for 10 min, the sections were
incubated with 5% bovine serum albumin for 60 minutes
in order to block the nonspecific binding, and then were
incubated with goat anti-rat Tim-3 primary antibody
(1:100; R&D systems, Minneapolis, MN, USA. http://
www.rndsystems.com/) at 4°C all the night. After being
washed three times with PBS, the sections were incu-
bated with secondary antibody goat anti-rabbit IgG
(1:100; KPL, Maryland, USA. http://www.kpl.com/home.
cfm) for 60 minutes at the room’s temperature. The sec-
tions were rinsed 3 × 5 min and were coverslipped with
ProLong antifade medium (Molecular Probes, Eugene,
OR, USA). The Tim-3 positive cells were visualized
using a fluorescent microscope (Olympus BX51, Japan).
For each animal, six representative sections of each brain
were selected. Tim-3 positive cells were counted blindly
in the approximately 40,000 μm 2 of brain tissues around
blood clot. In order to further identify the cellular re-
source of Tim-3 after ICH, double immunofluorescence
labeling [9] was performed by simultaneous incubation
of goat anti-rat Tim-3 primary antibody with rat anti-
mouse CD11b (1:200, eBioscience San Diego, CA, USA.
http://www.ebioscience.com/) as marker of activated
microglia/macrophage, or rabbit anti-GFAP (1:200,
Invitrogen, Carlsbad, CA, USA. www.invitrogen.com) as
marker of astrocyte, or rabbit anti-MPO (1:100, Dako,
Denmark. www.dako.com) as mark of neutrophils. In
each group, the number of CD11b positive cells (acti-
vated microglia/macrophage), GFAP positive cells (astro-
cyte) and MPO positive cells (neutrophils) were counted
using the same method as used for Tim-3 positive cells.
Ipp6.0 image processing software was utilized to count
the number of Tim-3 positive cells.
Real-time reverse transcription polymerase chain reaction
According to the methods described previously [15],
frozen mice brains were homogenized, and total RNA
was obtained from about 4 × 4 × 4 mm3 volume of peri-
hematomal tissues (blood clot as center under a stereo-
microscope) at 12 hours and at 1, 3, 5 and 7 days post-ICH
using Trizol reagent (Invitrogen, Carlsbad, CA, USA) in
compliance with the manufacture’s instruction. The char-
acter of RNA was tested by a spectrophotometer (DU800,
Beckman, Palo Alto, CA, USA). The M-MLV Reverse
Transcriptase System (Promega, Madison, WI, USA) was
performed for reverse transcription. The cDNA was
stored at −20°C. Quantitative real-time PCR was fulfilled
with a LightCycler (Roche Diagnostics, Mannheim, GM)
and with SYBR Green I in SYBR RT-PCR Kit (TaKaRa
Biotechnology, Dalian, China) so as to enlarge and detect
the expression of Tim-3 mRNA. The transcript amount of
the rat β-actin housekeeping gene was quantified as an in-
ternal RNA control. Primers were purchased from BioAsia
Corp. (Shanghai, China). The primer sequences were as
follows: β-actin forward: 5’-GGCATCGTGATGGACT
CCG −3’ and β-actin reverse: 5′-GCTGGAAGGTGGA
CAGCGA −3′; Tim-3 forward: 5′ACTGGTGACCCTCC
ATAATAACA −3′ and Tim-3 reverse: 5′ATTTTCCTCA
GAGCGAATCCT −3′. Experiments were carried out in
triplicate for each data point. A threshold cycle value (CT)
was calculated by the ΔΔCT method as previously de-
scribed [17]. The data were analyzed by using Light Cycler
Software 4.0 (Roche Diagnostics).
Enzyme-linked immunosorbent assay
IL-1β and TNF-aare two important inflammatory media-
tors and can represent the severity of brain inflamma-
tion after ICH. The concentrations of IL-1β and TNF-a
in brain tissues of the peri-hematomal region were
detected via the ELISA method according to the manu-
facturer’s instructions (R&D systems, Minneapolis, MN,
USA). Brain tissues were centrifuged at 12000 rps for
20 min and the supernatant was collected for analysis.
The detection threshold of this assay was <1 pg/mL.
Brain water content
Brain water content indicates the degree of brain edema,
which is mainly due to peri-hematomal inflammation
and blood–brain barrier breakdown. Brain samples were
immediately weighed on an electric analytical balance to
get the wet weight, and then dried at 100°C for 24 hours
to obtain the dry weight. Brain water content (%) = (wet
weight - dry weight)/wet weight of brain tissue × 100.
Testing of neurological deficit scores
At 12 hours and at 1, 3, 5 and 7 days after operation, the
neurofunctional abnormality of mice was tested and
scored in each group. An observer blinded to the
identity of the mice evaluated behavior. Three behavioral
examinations, including ipsilateral circling, forelimb
flexion and beam balance were used as described before
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[18]. Each point is graded from 0 to 4. The maximum
abnormal score is 12.
Statistical analysis
All statistical analyses were performed with SPSS 16.0
for Windows (Chicago, IL, USA). Data are presented as
mean ± standard deviation (SD). Multiple group differ-
ences were analyzed using one-way or two-way analysis
of variance and Student-Newman-Keuls test in post hoc
tests. An independent-samples t-test was adopted for
comparison of the two groups. The correlation analysis
was completed by bivariate. P <0.05 was considered as
the indication of statistical significance.
Results
The physiological parameters in four groups during
production of hematoma
During production of hematoma, we monitored rectal
temperature, MABP, arterial pH, arterial PO2, PCO2, Hb,
and glucose levels in the four groups. The results showed
there was no difference among all groups (P > 0.05)
(Table 1).
Increase of Tim-3 expression in the peri-hematomal brain
tissues
In order to investigate the expression of Tim-3 in the
peri-hematomal brain tissues, we observed the number
of Tim-3 positive cells in the peri-hematomal brain
tissues at 12 hours and at 1, 3, 5 and 7 days post-ICH.
Results indicated that the number of Tim-3 positive cells
in the WT ICH group began to increase at 12 hours,
peaked at Day 1, and decreased at Day 3 after ICH.
There was a significant difference when compared with
that of WT sham mice in all time-tested points (P < 0.01)
(Figure 1A,B). Furthermore, we studied Tim-3 mRNA
expression in the peri-hematomal brain tissues at 12 hours
and at 1, 3, 5 and 7 days post-ICH using a real-time RT-
PCR method. The change trend of Tim-3 mRNA was
similar to the number of Tim-3 positive cells. The Tim-3
mRNA expression was strikingly upregulated in the peri-
hematomal brain tissues after ICH at 12 hours, peaked at
Day 1, and descended at Day 3. The Tim-3 mRNA expres-
sion was significantly different when compared with that
in WT sham group(P < 0.01) (Figure 1C).
Preponderant expression of Tim-3 in microglia/macrophages
To identify the cellular resource of Tim-3 expression, we
observed double-immunofluorescence staining. The results
revealed that expression of Tim-3 was preponderant in
CD11b+ cells (microglia/macrophages), was lower in
MPO+ cells (neutrophils), and was lowest in GFAP+
cells (astrocytes) (Figure 2).
Obvious increase of IL-1β, TNF-a and brain water content
in the peri-hematomal brain tissues
IL-1β and TNF-a are two main proinflammatory cyto-
kines of microglial source, which represent the level of
brain inflammation [19,20]. We detected the concentra-
tion of IL-1β and TNF-a in the peri-hematomal brain
tissues at 12 hours and at 1, 3, 5 and 7 days post-ICH.
Both of them elevated obviously in the WT ICH group
at all tested time points. There was significant difference
between the WT ICH group and the WT sham group
(P < 0.01). IL-1β and TNF-a increased at 12 hours after
ICH, and peaked at Day 1, then decreased at Day 3
(Figure 3A,B). We also measured the mice brain water
content to judge the degree of brain edema. Brain water
content heightened at 12 hours after ICH, peaked at Day
1 and Day 3, and then gradually declined. There was a
significant difference between the WT ICH group and
the WT sham group (P < 0.01) (Figure 3C).
Positive correlation of expression of Tim-3 with IL-1β,
TNF-a and brain water content
We analyzed the correlation between expression of
Tim-3 and IL-1β, TNF-a and brain water content.
The results show that expression of Tim-3 was posi-
tively correlated with IL-1β (r = 0.618, P <0.001),
TNF-a (r = 0.610, P <0.001) and brain water content
(r = 0.566, P = 0.001)(Figure 4A,B,C).
Table 1 Comparison of physiological parametersa (PP) in all groups during production of hematoma
WT sham group (n = 60) WT ICH group (n = 60) Tim-3−/− sham group (n = 50) Tim-3−/− ICH group (n = 50)
Rectal temperature 36.97 ± 0.54 37.12 ± 0.42 37.06 ± 0.49 37.01 ± 0.39
MABP(mmHg) 100.04 ± 1.86 101.22 ± 1.96 99.75 ± 2.09 100.09 ± 1.66
Arterial pH 7.38 ± 0.04 7.41 ± 0.02 7.40 ± 0.05 7.35 ± 0.02
PO2(mmHg) 106.57 ± 8.50 110.21 ± 5.84 109.86 ± 9.71 103.34 ± 5.04
PCO2(mmHg) 42.54 ± 4.12 41.58 ± 2.71 41.77 ± 3.07 42.37 ± 3.42
Hb(g/L) 149.17 ± 6.79 147.01 ± 6.86 143.49 ± 8.64 149.06 ± 7.48
Glucose (mg/dL) 135.90 ± 14.76 137.16 ± 8.47 134.64 ± 16.38 137.72 ± 10.08
aData were presented as mean ± standard deviation. The physiological parameters were not differentamong all groups. P > 0.05.ICH, intracerebral hemorrhage;
Tim-3, T cell immunoglobulin and mucin domain-3; WT, wild type.
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The brain inflammatory response, brain edema and
neurologic function in the Tim-3−/− ICH mice
To further prove the effects of Tim-3 on brain inflam-
mation, brain edema and neurologic function, we com-
pared the concentration of IL-1β and TNF-a, brain
water content and NDS in the WT ICH group with that
in the Tim-3−/− ICH group. The concentration of both
IL-1β and TNF-a in the peri-hematomal brain tissues
notably decreased in the Tim-3−/− ICH group, and there
was significant difference compared to that in the WT
ICH group (the Tim-3−/− ICH group versus the WT
ICH group, IL-1β: 12 h P <0.01; 1d P <0.05; 3 d P <0.05;
5d P <0.05; 7d P <0.01. TNF-a: 12 h P <0.05; 1d
P <0.05; 3d P <0.01; 5d P <0.01; 7d P <0.01) (Figure 3A,B).
Brain water content also markedly declined in the
Tim-3−/− ICH group in all tested time points (the
Tim-3−/− ICH group versus the WT ICH group, 12 h
P <0.01; 1d P <0.01; 3 d P <0.01; 5d P <0.01; 7d P <0.05.)
(Figure 3C). At 12 hours and day 1, there was no differ-
ence of NDS between the Tim-3−/− ICH group and the
WT ICH group. At 3 days, the NDS of the Tim-3−/− ICH
group was lower than that of the WT ICH group, but
there was no statistical difference. At 5 and 7 days, there
was a significant difference between two groups (P < 0.05)
(Figure 3D), which meant that blockage of expression of
Tim-3 could improve the neurological deficit after ICH.
The change of astrocytes, neutrophils and microglia/
macrophages after intracerebral hemorrhage
We investigated the number of astrocytes, neutrophils and
microglia/macrophages in all groups using immunofluor-
escence staining. The results indicated that the number of
Figure 1 Expression of Tim-3 positive cells and Tim-3 mRNA in peri-hematomal brain tissues at time-tested points following intracerebral
hemorrhage (ICH). A) and B) Immunofluorescence staining showed that the number of Tim-3 positive cells increased at 12 hours in the wild type
(WT) ICH group mice (n = 6), with the maximum at Day 1, **P <0.01 versus the WT sham group (mean ± SD). Scale bar = 20 μm. C) Real-time RT-PCR
indicated that the expression of Tim-3 mRNA increased at all time-tested points in the ICH group mice (n = 6) and peaked at Day 1. **P <0.01 versus
WT sham group (mean ± SD). ‘Relative fold’ meant the level of mRNA of Tim-3 relative to that of beta-actin.
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astrocytes, neutrophils and microglia/macrophages all
increased after ICH. But the peak times of the three cells
were different. The number of astrocytes elevated at Day
1, peaked at Day5 and Day 7. The number of neutrophils
rose at 12 hours, peaked at Day 3, and then gradually
declined. But the number of astrocytes and neutrophils
were not different between the WT ICH group and the
Tim-3−/− ICH group. The number of microglia/macro-
phages increased at 12 hours and peaked at Day 1. This
variation was the same as that of Tim-3, IL-1β and TNF-a.
In Tim-3−/− ICH mice, the number of microglia/macro-
phages was obviously less than that of WT ICH mice and
there was a significant difference between the two groups
(P < 0.01) (Figure 5).
Discussion
In the present study we wanted to prove the effect of
Tim-3 on brain inflammation after ICH. Three aspects
of this research had to be addressed. The first aspect
involved the expression of Tim-3 in the peri-hematomal
zone after ICH. The second was related to the cellular
resource of Tim-3 expression. The third was concerned
with the correlation between the expression of Tim-3
and the severity of inflammatory response and brain
edema. Furthermore, we examined the change in the
release of inflammatory cytokines, brain edema, neuro-
functional impairment and inflammatory cells (astrocytes,
neutrophils and microglia/macrophages) in Tim-3−/− ICH
mice.
The expression of Tim-3 in the peri-hematomal zone after
ICH
Tim-3 is a new immuno-regulation molecule. It has
been proved that Tim-3 extensively expresses itself in
innate immune cells, including microglia, monocytes,
mast cells, dendritic cells and natural killer cells, and
plays complex roles in immune regulation and tolerance
[11,13,14,21-23]. Tim-3 is involved in several inflam-
matory diseases, such as experimental autoimmune en-
cephalomyelitis (EAE) [11], non-obese diabetes [24] and
Coxsackievirus B3-induced myocarditis [21]. Anderson
et al. [14] demonstrated that Tim-3 mRNA levels were
much higher in inflamed white matter tissue in patients
with multiple sclerosis (MS) and rat MS models, and
Figure 2 The expression of Tim-3 in different brain cells at day 1 after intracerebral hemorrhage (ICH). Double-immunofluorescence
staining displayed that: A) A few of Tim-3 positive cells could express in GFAP+ cells (astrocytes). B) A few of Tim-3 positive cells could express in
MPO+ cells (neutrophils), but more than were expressed in GFAP+ cells (astrocytes). The arrows indicate co-expressed cells of Tim-3 and MPO. C)
Almost all CD11b+ cells (microglia/macrophages) were Tim-3 positive cells at day 1 after ICH. The arrows indicate co-expressed cells of Tim-3 and
CD11b. Scale bar = 20 μm.
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Tim-3 upregulated on CD11b+ peripheral monocytes
and resident microglia to promote TNF-a secretion.
Zhao et al. [25] investigated the expression of Tim-3 in
the acute phase of ischemic stroke, and indicated that
overexpression of Tim-3 both in brain tissues of ischemia-
reperfusion mice and in peripheral blood mononuclear
cells of patients with ischemic stroke positively corre-
lated with plasma IL-17 and TNF-α. All these researchers
suggested that Tim-3 took parts in inflammatory-im-
munologic reaction. But it is completely unknown
whether or not Tim-3 plays roles in ICH. Now, we have
experimentally found that Tim-3 increases in the mouse
Figure 3 The change of IL-1β, TNF-a, brain water content and neurological deficit scores (NDS) after intracerebral hemorrhage (ICH). A)
indicates the change of the concentration of IL-1β in the peri-hematomal brain tissues at 12 hours andat 1, 3, 5 and 7 days post-ICH. B) shows
the change of the concentration of TNF-a. C) displays the change of brain water content. D) shows the NDS between the Tim-3−/− ICH group
and the wild type (WT) ICH group. The WT ICH group (n = 6) versus the WT sham group (n = 6): **P <0.01; The Tim-3−/− ICH group (n = 6) versus
the Tim-3−/− sham group (n = 6): &&P < 0.01; The Tim-3−/− ICH group (n = 6) versus the WT ICH group (n = 6): #P < 0.05, ##P < 0.01.
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peri-hematomal brain tissues early after autologous
blood injection and progressively increasesand accom-
panies the development of brain inflammation, suggesting
that Tim-3 is also involved in the inflammatory response
following ICH.
The cellular resource of Tim-3 expression
Previous studies have revealed that brain inflammation
after ICH was characterized by the soakage of neutro-
phils and macrophages from blood and activation of
microglia in brain tissues [8,26]. Among all inflamma-
tory cells, microglia are the first non-neuronal cells to
react to brain damage [27]. The shape of activated
microglia is the same as the shape of blood-derived
macrophages, so it is impossible to discriminate them
from infiltrating macrophages. Microglia are activated at
1 hour after ICH, much earlier than neutrophil infiltration,
and the latter appears at 4 to 5 h after ICH [9]. Activated
microglia/macrophages can release cytotoxic mediators,
such as IL-1β and TNF-a, inducing brain inflammatory
reaction and secondary damage [10,15,28]. Blockage of
microglia activation with tuftsin fragment 1–3 can attenu-
ate neuroinflammation and brain damage after ICH in rats
[24,29]. In this experimental study, we found that the
expression of Tim-3 following ICH was preponderant in
microglia/macrophages, was lower in neutrophils, and
was lowest in astrocytes. Although astrocytes, neutrophils
and microglia/macrophages all increased following ICH,
but only variation of microglia/macrophages was the same
as that of Tim-3, IL-1β and TNF-a. These indicate that
Tim-3 can inhibit the activation of microglia/macro-
phages, but not influence the astrocytes and neutrophils.
Tim-3 not only expressed in microglia/macrophages, but
also could regulate the function of them.
Figure 4 The correlation between the expression of Tim-3 and IL-1β, TNF-a, brain water content. A), B) and C) indicate that
the expression of Tim-3 was positively correlated with IL-1β (r = 0.618, P <0.001), TNF-a (r = 0.610, P <0.001) and brain water content
(r = 0.566, P = 0.001).
Figure 5 The change of the number of astrocytes, neutrophils and microglia/macrophages after intracerebral hemorrhage (ICH). A)
indicates the change in the number of astrocytes in the peri-hematomal brain tissues at 12 hours and at 1, 3, 5 and 7 days post-ICH. B) shows
the change in the number of neutrophils. C) displays the change in the number of microglia/macrophages in the wild type (WT) ICH group
(n = 6) versus the WT sham group (n = 6): **P <0.01; The Tim-3−/− ICH group (n = 4) versus the Tim-3−/− sham group (n = 4): &&P <0.01; the
Tim-3−/− ICH group (n = 4) versus the WT ICH group (n = 6): ##P <0.01.
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The relationship between the expression of Tim-3 and the
severity of inflammatory response and brain edema
IL-1β and TNF-a are two important proinflammatory
cytokines, which can drive the inflammatory process and
aggravate inflammation [30,31]. Although IL-1β and TNF-
a are released by many cells, including microglia/macro-
phages, astrocytes and neurons, the major source of these
are activated microglia/macrophages [4,19,20]. Many
experimental data have revealed that expression of IL-1β
and TNF-a increase after ICH, and are associated with
brain edema and brain damage. Increased expression of
IL-1β and TNF-a can been detected not only in the
central nervous system but also in systemic circulation
[32-34]. IL-1β and TNF-α can boost inflammatory reac-
tion in the early stage by promoting secretion of other
chemotactic factors and adhesion molecules of the vascu-
lar endothelium, which can lead to the early infiltration of
macrophages and neutrophils to the injury lesion [35,36].
The levels of TNF-α and IL-1β can represent the severity
of brain inflammatory to a great degree. In our study, we
found that TNF-α and IL-1β increased at 12 hours post-
ICH, peaked at Day 1 and decreased at Day 3 after ICH.
The expression of Tim-3 is positively correlated to levels
of TNF-α, IL-1β and brain water content. Above all, we
can deduce that augmented Tim-3 expression may pro-
mote inflammation and brain edema in the peri-
hematomal tissues after ICH by regulating the function of
microglia/macrophage. This result was supported by three
points below. First of all, expression of Tim-3 increased
early in the perilesional tissue and predominantly ex-
pressed itself in microglia/macrophages after ICH. The
number of microglia/macrophages was much lower in
Tim-3−/− ICH mice. Furthermore, the secretion of TNF-α
and IL-1β elevated in the peri-hematomal tissues follow-
ing ICH, and microglia/macrophages are the major types
of cells to secrete TNF-a and IL-1β. In addition, there was
a positive correlation between the expression of Tim-3
and the levels of TNF-α, IL-1β and brain water content.
Blocking expression of Tim-3 could not only reduce the
levels of TNF-α, IL-1β, brain water content and the num-
ber of microglia/macrophages, but also improve neuro-
logical function, which also elucidated the effect of Tim-3
on brain inflammatory reaction from another aspect. But
the signal pathways of Tim-3 that regulate the function of
microglia/macrophages need to be further explored.
Conclusions
Tim-3 plays an important role in the brain inflammation
after ICH by regulating the function of microglia/macro-
phages and may be a potential treatment target.
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